Aumet, a Saudi Arabia-based healthtech company developing AI-powered procurement solutions for healthcare providers, has secured $12 million in a Series A funding round led by Emkan Capital, with participation from regional and international investors. The funding will support product development, AI expansion, and international growth.
Building an AI Operating System for Healthcare
Founded in 2016, Aumet has evolved from a healthcare marketplace into a comprehensive procurement operating system serving pharmacies, hospitals, and healthcare networks. The platform processes more than five million transactions annually, connects over 1,000 pharmaceutical suppliers, and has generated more than $1 billion in GMV across 12,000 pharmacies.
The company offers three core solutions: Pulse for pharmacies, Chain for pharmacy groups, and Enterprise, an AI-powered procurement platform for hospitals, ministries of health, and national healthcare systems.
Growing Enterprise Adoption
Aumet’s Enterprise platform has already been deployed across 32 hospitals and more than 500 medical centers in Jordan, including Al-Basheer Hospital, through a collaboration with Jordan’s Ministry of Health and Presight.
“Healthcare supply chains don’t suffer from lack of supply — they suffer from lack of intelligence,” said Yahya Aqel, CEO and Co-founder of Aumet. “At Aumet, we are building the AI-first operating system that powers procurement decisions across the entire healthcare ecosystem — from individual pharmacies to national healthcare systems. Our ambition is to take what we’ve built in the Middle East and scale it globally.”
Expanding Across New Markets
The investment was backed by Emkan Capital, Qatar Development Bank, SABAH VC, AAIC, Shorooq Partners, Right Side Capital Management, and strategic healthcare investors.
The new capital will be used to strengthen AI capabilities, expand Enterprise deployments across larger healthcare networks, scale pharmacy solutions globally, and support expansion into GCC and international markets.